Evaluation of selective and non-selective cyclooxygenase inhibitors on sulfur mustard-induced pro-inflammatory cytokine formation in normal human epidermal keratinocytes. (15th September 2019)
- Record Type:
- Journal Article
- Title:
- Evaluation of selective and non-selective cyclooxygenase inhibitors on sulfur mustard-induced pro-inflammatory cytokine formation in normal human epidermal keratinocytes. (15th September 2019)
- Main Title:
- Evaluation of selective and non-selective cyclooxygenase inhibitors on sulfur mustard-induced pro-inflammatory cytokine formation in normal human epidermal keratinocytes
- Authors:
- Wagner, Simon
Lang, Simon
Popp, Tanja
Schmidt, Annette
Thiermann, Horst
Steinritz, Dirk
Kehe, Kai - Abstract:
- Abstract: Sulfur mustard (SM) is a highly toxic chemical warfare agent, which produces blisters after skin contact. Treatment of SM-induced adverse health effects, such as cutaneous blistering, ulceration, and inflammation remains a challenging task. Antidotes or specific therapeutic measures are lacking. Some drugs ( e.g. cyclooxygenase (COX) inhibitors) exhibited beneficial effects after SM poisoning in vivo . However, in vitro studies that evaluate and compare the potency of COX inhibitors are missing. In the presented study, non-specific (acetylsalicylic acid, ibuprofen, diclofenac, indomethacin, and piroxicam), COX-2-specific (celecoxib and parecoxib) inhibitors and COX-independent drugs (paracetamol and tofacitinib) were compared regarding anti-inflammatory and cytoprotective effects after SM exposure in post-exposure treatment settings. Normal human epidermal keratinocytes (NHEK) were used as a surrogate model. Prostaglandin E2 (PGE2 ) formation, a direct indicator for COX activity, was determined by ELISA. Changes in pro-inflammatory cytokine levels after SM exposures were assessed by quantitative determination of 27 inflammatory cytokines using a multiplex method. Cytotoxicity was determined using an XTT viability assay. The results demonstrated that SM highly increased PGE2 production and release of pro-inflammatory cytokines, predominantly IL-6, IL-8 and TNF-α. In general, all COX inhibitors and paracetamol were able to reduce the PGE2 formation, whileAbstract: Sulfur mustard (SM) is a highly toxic chemical warfare agent, which produces blisters after skin contact. Treatment of SM-induced adverse health effects, such as cutaneous blistering, ulceration, and inflammation remains a challenging task. Antidotes or specific therapeutic measures are lacking. Some drugs ( e.g. cyclooxygenase (COX) inhibitors) exhibited beneficial effects after SM poisoning in vivo . However, in vitro studies that evaluate and compare the potency of COX inhibitors are missing. In the presented study, non-specific (acetylsalicylic acid, ibuprofen, diclofenac, indomethacin, and piroxicam), COX-2-specific (celecoxib and parecoxib) inhibitors and COX-independent drugs (paracetamol and tofacitinib) were compared regarding anti-inflammatory and cytoprotective effects after SM exposure in post-exposure treatment settings. Normal human epidermal keratinocytes (NHEK) were used as a surrogate model. Prostaglandin E2 (PGE2 ) formation, a direct indicator for COX activity, was determined by ELISA. Changes in pro-inflammatory cytokine levels after SM exposures were assessed by quantitative determination of 27 inflammatory cytokines using a multiplex method. Cytotoxicity was determined using an XTT viability assay. The results demonstrated that SM highly increased PGE2 production and release of pro-inflammatory cytokines, predominantly IL-6, IL-8 and TNF-α. In general, all COX inhibitors and paracetamol were able to reduce the PGE2 formation, while tofacitinib, an inhibitor of Janus kinase, had no influence on PGE2 levels. In addition, IL-6, IL-8, and TNF-α formation were also inhibited, but sometimes independently of PGE2 . The COX-2 specific celecoxib was identified as the most potent drug to reduce IL-6, IL-8 and TNF-α formation after SM exposures in vitro . However, cell viability was not improved significantly by any of the investigated drugs in our experiments. … (more)
- Is Part Of:
- Toxicology letters. Volume 312(2019)
- Journal:
- Toxicology letters
- Issue:
- Volume 312(2019)
- Issue Display:
- Volume 312, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 312
- Issue:
- 2019
- Issue Sort Value:
- 2019-0312-2019-0000
- Page Start:
- 109
- Page End:
- 117
- Publication Date:
- 2019-09-15
- Subjects:
- ASA acetylsalicylic acid -- AU artificial units -- CaCl2 calcium chloride -- COX cyclooxygenase -- DMSO dimethyl sulfoxide -- ELISA enzyme-linked immunosorbent assay -- EtOH ethanol -- IL-6 interleukin-6 -- IL-8 interleukin-8 -- JAK-STAT Janus kinase-signal transducers and activators of transcription -- KGM2 keratinocyte growth medium 2 -- NHEK normal human epidermal keratinocytes -- NF-kB nuclear factor kappa-light-chain-enhancer of activated b-cells -- NSAID non-steroidal-anti-inflammatory-drug -- PBS phosphate buffered saline -- PGE2 prostaglandin E2 -- SM sulfur mustard -- TNF-α tumor necrosis factor-alpha
COX -- NSAID -- NHEK -- Sulfur mustard -- PGE2 -- IL-6 -- IL-8 -- TNF-α
Toxicology -- Periodicals
363.179 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03784274 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.toxlet.2019.03.012 ↗
- Languages:
- English
- ISSNs:
- 0378-4274
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8873.042000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10931.xml